Previous 10 | Next 10 |
Seelos Therapeutics to Participate in the 2021 RBC Capital Markets Global Healthcare Conference PR Newswire NEW YORK , April 19, 2021 /PRNewswire/ -- Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the developm...
The Hottest Penny Stock Trends And How to Use Them to Your Advantage Penny stocks are the talk of the town and for good reason. Throughout 2020 and 2021, investors have been searching high and low to find the best penny stocks to watch . And while some traders are more experienced t...
People are quickly waking up to the potential benefits of psilocybin. In fact, former Texas Gov. Rick Perry just threw his support behind a bill that could create a study to look at psilocybin and its potential impact on veterans with PTSD. While Perry has said he’s “historica...
Gainers: Wilhelmina International (WHLM) +25%.Kaleido Biosciences (KLDO) +14%.Ardelyx (ARDX) +14%.PLBY Group (PLBY) +14%.Talis Biomedical (TLIS) +14%.Wah Fu Education (WAFU) +12%.Seelos Therapeutics (SEEL) +11%Inpixon (INPX) +11%.BCTG Acquisition (BCTG) +10%.Ballantyne Strong (...
Which Biotech Penny Stocks Are Investors Watching Today? Biotech penny stocks remain some of the most popular securities in 2021. While Covid has helped to highlight the industry at large, each individual company has something different to offer. When looking for a biotech penny stock, ...
Seelos Therapeutics to Participate in the B. Riley Securities' Neuroscience Conference PR Newswire NEW YORK , April 15, 2021 /PRNewswire/ -- Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapi...
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – April 13, 2021 – As an urgent public mental health crisis forces research institutions and governments to seriously examine unconventional mental health solutions, psychedelic assisted t...
These days, we can make a very strong case for mind-altering treatments for mental health. Not only is the US FDA supportive of its use, but countless studies from some of the world’s leading companies are showing just how useful it can be, including Silo Wellness (CSE:SILO),...
BTIG analyst Bert Hazlett is reiterating his buy recommendation and $14 price target for shares of Seelos Therapeutics (SEEL) following yesterday's device partnership with Aptar Pharma (ATR).That deal calls for the use of the Aptar Bidose Liquid System device for Seelos’s intranas...
Are Psychedelic Penny Stocks On Your Watch List Right Now? If you’re looking for high-risk, high-reward, penny stocks could be a perfect fit. Not many other investment options offer the ability to leverage small sums of money that can double or triple within a few days or even ho...
News, Short Squeeze, Breakout and More Instantly...
Seelos Therapeutics Inc. Company Name:
SEEL Stock Symbol:
NYSE Market:
Seelos Therapeutics Inc. Website:
The U.S. Drug Enforcement Administration (DEA) is claiming that a federal law that affords severely ill individuals the right to try investigational medications doesn’t apply to drugs classified under the Controlled Substances Act. This is in response to a lawsuit filed by a doctor in ...
Seelos Therapeutics Announces Strategic Focus on Mental Health Initiatives and Provides an Update on Current Discussions of Potential Partnerships and Collaborations PR Newswire - Richard Pascoe appointed Chairman of the Board of Directors to spearhead the ongoing busi...
A recently published review has determined that using psilocybin to manage mental-health conditions doesn’t heighten the risk of paranoia. This discovery comes at a time when public interest in the therapeutic potential of psychedelics is increasing. The review was carried out by resea...